Literature DB >> 29609086

Primary Central Nervous System Hodgkin Lymphoma-Like Posttransplant Lymphoproliferative Disorder.

Yusuke S Hori1, Keina Nagakita2, Yuki Ebisudani3, Mizuho Aoi3, Toru Fukuhara3, Yoko Shinno2.   

Abstract

BACKGROUND: Posttransplant lymphoproliferative disorder (PTLD) is a rare condition occurring after organ transplantation. PTLD comprises 4 subtypes, of which Hodgkin lymphoma (HL) type and HL-like type (currently included in polymorphic type) account for only about 1%-3% of cases. Primary central nervous system PTLD is also rare; most cases are Epstein-Barr virus-positive, B-cell PTLD. To our knowledge, no case of HL-like PTLD has been documented. CASE DESCRIPTION: A 43-year-old woman who underwent kidney transplantation for IgA nephropathy 14 years previously presented to the emergency department with seizure. Gadolinium-enhanced T1-weighted magnetic resonance imaging showed a ring-enhancing mass in the left temporal lobe. Gross total removal of the tumor was performed, and pathologic examination revealed findings consistent with HL-like PTLD. The patient's immunosuppressants were subsequently reduced, and she received postoperative systemic therapy with rituximab and radiation therapy. Follow-up magnetic resonance imaging showed no signs of relapse.
CONCLUSIONS: This represents an extremely rare case of a patient with HL-like PTLD occurring as a primary central nervous system lesion.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B-cell lymphoma; Hodgkin lymphoma; Posttransplant lymphoproliferative disorder; Primary central nervous system lymphoma

Mesh:

Year:  2018        PMID: 29609086     DOI: 10.1016/j.wneu.2018.03.153

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  1 in total

1.  Case Report: Primary Indolent Epstein-Barr Virus-Positive T-Cell Lymphoproliferative Disease Involving the Central Nervous System.

Authors:  Kun Wang; Jinjian Li; Xuehui Zhou; Junhui Lv; Yirong Wang; Xinwei Li
Journal:  Front Surg       Date:  2022-03-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.